Pancreatic Cancer Research

ResearcherTokyo Medical UniversityActive in the last 2 years

Kazuhiko Kasuya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7260-4378; OpenAlex author ID A5103031078, A5133195063. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1245/s10434-026-19546-9↗
  2. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic … Co-author DOI 10.1007/s00280-017-3288-7↗
  3. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Co-author DOI 10.3390/ijms18040767↗
  4. Pancreaticoduodenectomy with right-oblique posterior dissection of superior mesenteric nerve plexus is logical procedure for pancreatic cancer with extrapancre… Co-author PMID 25699385↗
  5. Single nucleotide polymorphism of multidrug-resistance 1 and anti- multidrug-resistance 1 single chain antibody treatment for the pancreatic cancer cell line. Co-author DOI 10.5754/hge11377↗
  6. Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism an… Co-author DOI 10.5754/hge11729↗
  7. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Co-author DOI 10.3892/or.2011.1457↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takao Itoi · 4 shared papers, 2012–2026 · strength 0.36
  2. Jean Closset · 1 shared paper, 2026 · strength 0.24
  3. D. Nageshwar Reddy · 1 shared paper, 2026 · strength 0.24
  4. James Lau · 1 shared paper, 2026 · strength 0.24
  5. Sergio Alfieri · 1 shared paper, 2026 · strength 0.24
  6. Guido Costamagna · 1 shared paper, 2026 · strength 0.24
  7. Rohit Chandwani · 1 shared paper, 2026 · strength 0.24
  8. Yuichi Nagakawa · 5 shared papers, 2012–2017 · strength 0.22
  9. Akihiko Tsuchida · 4 shared papers, 2012–2017 · strength 0.17
  10. Yuichi Hosokawa · 2 shared papers, 2014–2017 · strength 0.10
  11. Atsushi Sofuni · 2 shared papers, 2012–2017 · strength 0.08
  12. Yuta Abe · 2 shared papers, 2012–2017 · strength 0.08
  13. Koichi Tokuuye · 1 shared paper, 2017 · strength 0.06
  14. Tatsuya Aoki · 2 shared papers, 2012 · strength 0.06
  15. Makoto Sunamura · 1 shared paper, 2017 · strength 0.05
  16. Shigeyuki Kawachi · 1 shared paper, 2017 · strength 0.05
  17. Reina Tanaka · 1 shared paper, 2017 · strength 0.05
  18. Ryosuke Tonozuka · 1 shared paper, 2017 · strength 0.05
  19. Fuminori Moriyasu · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.